Kristie L. Kahl

A new study supported the use of a blood test to detect clusters of cancer cells in the blood of asymptomatic individuals, meaning, patients could have a non-invasive screening and testing method.

Patients with head and neck paragangliomas, a rare neuroendocrine tumor type, may be safely and effectively treated with proton therapy.

Ahead of Rare Disease Day, here is what you need to know about pheochromocytoma and paraganglioma, two rare types of tumors.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Zsofia Stadler, on behalf of the Colon Cancer Foundation, about the rising incidence of early-age onset colorectal cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in January.

A microsimulation model found that evolving approaches are associated with improved life expectancy among childhood cancer survivors – particularly for those who received chemotherapy alone.

In a first-of-its-kind analysis, researchers found that high body mass index may be associated with improved survival in Tecentriq-treated patients with advanced non–small cell lung cancer.

A study of the Veterans Affairs health system found that, despite trends suggesting otherwise, African American men with prostate cancer had similar survival outcomes, compared with non-Hispanic White men.

Survival among patients with myelofibrosis who discontinued treatment with Jakafi appeared to have poorer survival, which was most prominent in those who stopped during the blast phase of treatment.

In this week’s episode, a pair who is forever connected by their genetic risk for cancer talked about the revelations that came from a study they participated in that changed both of their lives.

Patients with high-risk stage 3 melanoma who experienced an immune-related side effect after treatment with adjuvant Keytruda had reduced risk for disease recurrence, compared with those on the placebo arm.

The Food and Drug Administration granted a priority review to belantamab mafodotin for the treatment of patients with relapsed or refractory multiple myeloma.

Oncoprex in combination with Tagrisso received fast track designation from the Food and Drug Administration to treat patients with non-small cell lung cancer.

Researchers found that men with prostate cancer who consumed a diet high in vegetable did not experience clinical benefit; however, overall health benefits were seen.

How providers communicate medical bills to payers and patients, mandated by the US Centers for Medicare & Medicaid Services, still did not help patients and health care professionals in understanding differences in cost.

A brief, multimodal psychosocial intervention for caregivers of patients undergoing hematopoietic stem cell transplantation could improve their quality of life, caregiving burden and anxiety and depression symptoms.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with the associate director of the Information Resource Center at the Leukemia and Lymphoma Society on support groups and other recourses available for those affected by blood cancer.

In a first-of-its-kind study, researchers have found an increase in alcohol consumption among cancer survivors that warrants further study and possible alcohol consumption screenings prior to treatment.

Researchers from Roswell Park Comprehensive Cancer Center found that the use of supplements, besides a multivitamin, while patients were being treated with chemotherapy increased their risk for breast cancer recurrence or death.

Findings from a recent study supported further evaluation of comparing anti–PD-1 to anti–PD-L1 therapy to help determine treatment options for patients with cancer.

Cancer mortality rates have declined significantly since 1991; however, certain cancer types have seen slower progression as of recently because of improved screening.

Researchers found that those who experienced a potentially burdensome end-of-life transition, were more likely not to receive hospice care.

This new option may save patients with high-risk non-muscle invasive bladder cancer from having to undergo a radical cystectomy to treat their disease.

Increasing doses, cutting pills and self-tapering of opioids can lead to safety risks for patients with cancer; however, this is an issue that often goes unaddressed.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with breast cancer survivor Felicia Robinson, who recently wrote a book with her daughter on their personal experiences with the various aspects of a life-changing diagnosis.

The Food and Drug Administration approved Keytruda for the treatment of patients with Bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer.

Researchers interviewed 24 cancer survivors to discuss the psychosocial aspects of hearing loss and why patients must advocate for themselves with this long-term condition sooner.

Concurrent chemoradiotherapy with proton radiation can reduce short-term side effects that caused unplanned hospitalizations, with similar disease-free and overall survival, compared with photon radiation.

The pivotal phase 3 GRAVITAS-301 study – designed to evaluate itacitinib in combination with corticosteroids in patients with treatment-naïve acute graft-versus-host disease – failed to meet its primary endpoint of improving overall response rates.

Patients with previously untreated locally advanced or metastatic urothelial carcinoma treated with Bavencio and best supportive care as a first-line maintenance therapy experienced significantly longer survival.